Benjamin A. Evans
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.5%
- Vibrio bacteria research studies
- Escherichia coli research studies
- Infections and bacterial resistance
Papers in
-
- Antibiotic Resistance in Bacteria 28
-
- Vibrio bacteria research studies 13
- Infections and bacterial resistance 5
- Escherichia coli research studies 4
- Co-authors
- Sebastian G. B. Amyes (8 shared papers)Ahmed Hamouda (11 shared papers)K. J. Towner (4 shared papers)Daniel E. Rozen (4 shared papers)S. G. B. Amyes (6 shared papers)Abdulrahman Alsultan (4 shared papers)Steve Paterson (2 shared papers)David Williams (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Microbial Genomics (5 papers)Current Pharmaceutical Design (3 papers)Frontiers in Microbiology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United KingdomMexicoEgypt
In The Last Decade
Benjamin A. Evans
39 papers receiving 1.9k citations
Benjamin A. Evans's Hit Papers
Peers
Comparison fields: 5 of 111
- Molecular Medicine 1.4k
- Endocrinology 743
- Applied Microbiology and Biotechnology 161
- Pollution 283
- Pharmacology 340
Countries citing papers authored by Benjamin A. Evans
This map shows the geographic impact of Benjamin A. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin A. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin A. Evans more than expected).
Fields of papers citing papers by Benjamin A. Evans
This network shows the impact of papers produced by Benjamin A. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin A. Evans. The network helps show where Benjamin A. Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin A. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | OXA β-Lactamases Hit paper breakdown → | 2014 | 626 |
| 2 | 2012 | 119 | |
| 3 | 2012 | 115 | |
| 4 | 2010 | 111 | |
| 5 | 2015 | 90 | |
| 6 | 2008 | 86 | |
| 7 | 2010 | 77 | |
| 8 | 2011 | 52 | |
| 9 | 2018 | 44 | |
| 10 | 2013 | 43 | |
| 11 | 2013 | 42 | |
| 12 | 2012 | 39 | |
| 13 | 2015 | 39 | |
| 14 | 2009 | 33 | |
| 15 | 2010 | 31 | |
| 16 | 2020 | 31 | |
| 17 | 2020 | 26 | |
| 18 | 2010 | 24 | |
| 19 | 2015 | 22 | |
| 20 | 2018 | 21 |
About Benjamin A. Evans
Benjamin A. Evans is a scholar working on Molecular Medicine, Endocrinology, Molecular Biology, Epidemiology and Plant Science, having authored 41 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (28 papers), Vibrio bacteria research studies (13 papers), Bacterial biofilms and quorum sensing (10 papers), Plant Pathogenic Bacteria Studies (6 papers), Infections and bacterial resistance (5 papers), Pneumonia and Respiratory Infections (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Escherichia coli research studies (4 papers). The work is most often cited by research in Molecular Medicine (1.4k citations), Endocrinology (743 citations), Applied Microbiology and Biotechnology (161 citations), Pollution (283 citations) and Pharmacology (340 citations). Benjamin A. Evans has collaborated with scholars based in United Kingdom, Mexico and Egypt. Frequent co-authors include Sebastian G. B. Amyes, Ahmed Hamouda, K. J. Towner, Daniel E. Rozen, S. G. B. Amyes, Abdulrahman Alsultan, Steve Paterson, David Williams, Sam Haldenby and Martin Walshaw. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Microbial Genomics, Current Pharmaceutical Design, Frontiers in Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.